Company: SUPN
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001356576-25-000055
Chunk: 130

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 130
---
Selling, general and administrative6,028 5,321 12,684 9,853 Total$7,507 $6,552 $15,575 $12,449 Stock Option The following table summarizes stock option activities:Number ofOptionsWeighted AverageExercise PriceWeightedAverageRemainingContractualTerm (in years)Outstanding, December 31, 20246,719,073 $30.44 5.9Granted 1,081,220 $33.82 Exercised (175,748)$23.01 Forfeited (97,131)$34.37 Outstanding, June 30, 2025 (unaudited)7,527,414 $31.04 6.1As of June 30, 2025 (unaudited):Vested and expected to vest7,527,414 $31.04 6.1Exercisable 4,800,080 $30.16 4.6As of December 31, 2024:Vested and expected to vest6,719,073 $30.44 5.9Exercisable4,137,283 $29.54 4.4Restricted Stock UnitsThe following table summarizes restricted stock unit (RSU) activities:Number ofRSUsWeighted AverageGrant Date Fair Value per ShareNonvested, December 31, 2024378,165 $32.48 Granted172,725 $33.50 Vested(136,673)$32.33 Forfeited(9,262)$32.30 Nonvested, June 30, 2025 (unaudited)404,955 $32.97 

16

Performance Share Units The following table summarizes performance share unit (PSU) activities:Performance-Based UnitsMarket-Based UnitsTotal PSUs Number of PSUsWeightedAverageGrant Date Fair Value per ShareNumber of PSUsWeightedAverageGrant Date Fair Value per ShareNumber of PSUsWeightedAverageGrant Date Fair Value per ShareNonvested, December 31, 2024324,685 $28.80 20,000 $28.63 344,685 $28.79 Granted246,496 $32.84 — $— 246,496 $32.84 Vested(114,415)$30.52 — $